| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/28/2007 | CA2148253C Allergenic proteins and peptides from johnson grass pollen |
| 08/28/2007 | CA2125763C P40 homodimer of interleukin-12 |
| 08/28/2007 | CA1341538C Dna encoding ige receptor alpha-subunit or fragment thereof |
| 08/24/2007 | CA2568981A1 Integrase-derived hiv-inhibiting agents |
| 08/23/2007 | WO2007095583A2 Methods for treating cancer and sensitizing cancer cells using the serine protease inhibitor, maspin |
| 08/23/2007 | WO2007095486A1 Methods of treating blepharospasm using cyclosporine components |
| 08/23/2007 | WO2007095151A2 Nerve regeneration employing keratin biomaterials |
| 08/23/2007 | WO2007094781A1 Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia |
| 08/23/2007 | WO2007094669A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation |
| 08/23/2007 | WO2007094495A2 Novel anticancer cathepsin preparation and anticancer agent for combination therapy against cancer using the same |
| 08/23/2007 | WO2007094462A1 Non-human animal having modified genome or offspring thereof |
| 08/23/2007 | WO2007094342A1 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
| 08/23/2007 | WO2007094340A1 Vasodilator |
| 08/23/2007 | WO2007094330A1 Peptide capable of activating bombesin-like peptide receptor and use thereof |
| 08/23/2007 | WO2007094137A1 Method of inducing cytotoxic t-cell, cytotoxic t-cell inducer and, produced therewith, pharmaceutical composition and vaccine |
| 08/23/2007 | WO2007094026A1 Prophylactic and/or therapeutic treatment of proliferative and conformational diseases |
| 08/23/2007 | WO2007093999A1 A gastro-retentive system for the delivery of macromolecules |
| 08/23/2007 | WO2007093839A1 New polypeptides kxk and their use |
| 08/23/2007 | WO2007093806A1 Dissolution aids for oral peptide delivery comprising a biguanide |
| 08/23/2007 | WO2007093220A1 Use of insulin-like factor 3 for treating osteoporosis and bone disorders |
| 08/23/2007 | WO2007093177A2 Metallothionein-derived peptide fragments |
| 08/23/2007 | WO2007093042A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | WO2007067597A3 Methods and compositions for needleless delivery of binding partners |
| 08/23/2007 | WO2007062819A3 Multimeric complexes of antigens and an adjuvant |
| 08/23/2007 | WO2007047614A3 Glycosylated probnp |
| 08/23/2007 | WO2007047205A8 Enzyme inhibitors of pai-1 |
| 08/23/2007 | WO2007014798A3 Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases |
| 08/23/2007 | WO2007014347A9 Method of treating a condition associated with phosphorylation of task-1 |
| 08/23/2007 | WO2007011875A3 Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders |
| 08/23/2007 | WO2007010370A3 Delta 6 desaturase from thraustochytrid & its uses thereof |
| 08/23/2007 | WO2006126086A3 Angiotensin i - converting enzyme (ace) inhibitors |
| 08/23/2007 | WO2006116565A3 Biodegradable peptide sustained release compositions containing porogens |
| 08/23/2007 | WO2006089015A3 Methods of using death receptor agonists and egfr inhibitors |
| 08/23/2007 | WO2006060664A3 Single-drug multi-ligand conjugates for targeted drug delivery |
| 08/23/2007 | WO2006044115A3 Method of treating parkinson's disease by convection-enhanced infusion of glial cell-line derived neurotrophic factor (gdnf) to the putamen |
| 08/23/2007 | WO2006009836A3 Tdf-related compounds and analogs thereof |
| 08/23/2007 | WO2005035003A9 Compositions and methods for increasing drug efficiency |
| 08/23/2007 | WO2004018698A3 Lectin compositions and methods for modulating an immune response to an antigen |
| 08/23/2007 | WO2004003176A9 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 08/23/2007 | WO2002097035A3 Secreted proteins |
| 08/23/2007 | WO2000024869A3 Methods for modulating cell fusion |
| 08/23/2007 | US20070199080 Diagnostic and therapeutic use of F-box proteins for Alzheimer's disease and related neurodegenerative disorders |
| 08/23/2007 | US20070197776 Hydrogels for protein concentration |
| 08/23/2007 | US20070197774 Adrenocorticotropic hormone analogs and related methods |
| 08/23/2007 | US20070197583 Novel compositions and methods for modulation of the acid-sensing ion channel (ASIC) for the treatment of anxiety and drug addiction |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/23/2007 | US20070197462 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus (EBV) or Kaposi's sarcoma-associated herpes (KHSV) |
| 08/23/2007 | US20070197459 Short interfering RNA for use in treatment of cell proliferative disorders |
| 08/23/2007 | US20070197458 Nucleic acid useful for triggering tumor cell lethality |
| 08/23/2007 | US20070197449 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 08/23/2007 | US20070197448 such as 2-Methyl-propane-2-sulfinic acid cyclohexylideneamide; coadministered with ribavirin, interferons |
| 08/23/2007 | US20070197447 Oligopeptide acetate and formulations thereof |
| 08/23/2007 | US20070197446 MHC binding peptides and their uses |
| 08/23/2007 | US20070197445 Neuropeptide Y receptor antagonists and agonists including O-glycosylated tripeptides, O-glycopeptides, and extended tripeptides; cardiovascular disorders; pancreatic polypeptide; peptide yy; pancreatitis; liver disorders |
| 08/23/2007 | US20070197444 Phage displayed cell binding peptides |
| 08/23/2007 | US20070197443 Methods and Compositions for Modulating Immunity |
| 08/23/2007 | US20070197442 Methods for the Treatment of Macular Degeneration and Related Eye Conditions |
| 08/23/2007 | US20070197441 Truncated il-17ra soluble receptor and methods of using in inflammation |
| 08/23/2007 | US20070197440 Blood coagulation factor VIIa having a purity of at least 1000 IU/mg of protein; purified from human plasma; free of proteins of nonhuman origin |
| 08/23/2007 | US20070197439 comprising glucocerebrosidase (GCB) and sucrose or trehalose in an amount sufficient to maintain the stability of the GCB, wherein the pH of the composition is less than 7.0; can be stored in liquid or lyophilized |
| 08/23/2007 | US20070197438 cathepsin mediated diseases; proteinuria, cancer, and cognitive diseases; podocyte cell gene transfer |
| 08/23/2007 | US20070197437 Compositions for enhanced epithelial permeation of y2 receptor-binding peptides |
| 08/23/2007 | US20070197436 Peptidyl diacylglycerides |
| 08/23/2007 | US20070197435 Process for the synchronization of ovulation for timed breeding without heat detection |
| 08/23/2007 | US20070197434 Theurapeutic or prophyiactic agent for arthritis |
| 08/23/2007 | US20070197433 Differentiation- Or Regeneration-Inducing Agent For Alveoli |
| 08/23/2007 | US20070197432 fusion protein comprising an amino acid sequence coupled to a single carrier keyhole limpet hemocyanin (KLH) protein and the bovine serum albumin (BSA) protein; vaccines; veterinary medicine |
| 08/23/2007 | US20070197431 Novel protein for inhibiting tumor progression and increasing nerve regeneration |
| 08/23/2007 | US20070197430 Conjugates And Therapeutic Uses Thereof |
| 08/23/2007 | US20070197429 cyclic peptides having one or more of the bridged cysteine-amino acid residue pairs of the naturally occurring or native conotoxin substituted with amino acids bearing a dicarba- and disulfide-bridges; solid phase synthesis; metathesis |
| 08/23/2007 | US20070197428 Novel indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
| 08/23/2007 | US20070197427 O,o'-amidomalonate and n,o-amidomalonate platinum complexes |
| 08/23/2007 | US20070197426 Lactoferrin polypeptide, process for producing the same and inflammation inducing substance |
| 08/23/2007 | US20070197425 comprising a thiazolidinedione, one or more of chromium picolinate or chromium polynicotinate; bioavailable source of vanadium is vanadyl sulfate; synergistic mixture |
| 08/23/2007 | US20070197424 Glatiramer acetate for use as an immuno-modulatory agent |
| 08/23/2007 | US20070196922 Methods and Compositions Relating to Restricted Expression Lentiviral Vectors and Their Applications |
| 08/23/2007 | US20070196897 Polynucleotides encoding a novel human g-protein coupled receptor splice variant, hgprbmy29sv2 |
| 08/23/2007 | US20070196883 Enzyme |
| 08/23/2007 | US20070196879 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 08/23/2007 | US20070196873 Pain signaling molecules |
| 08/23/2007 | US20070196865 Methods Of Screening Compositions For G Protein-Coupled Receptors Aganist Agonists |
| 08/23/2007 | US20070196859 Novel antibacterial agents |
| 08/23/2007 | US20070196857 Determination of risk and treatment of complications of prematurity |
| 08/23/2007 | US20070196829 Screening for an antibacterial agent by contacting a test compound with an isolated Pseudomonas aeruginosa protein LpxC, determining whether the test compound binds to the protein, and determining whether the test compound has either bactericidal or bacteriostatic activity against Pseudomonas aeruginosa |
| 08/23/2007 | US20070196810 Polymerized Hemoglobin Media and its Use in Isolation and Transplantation of Islet Cells |
| 08/23/2007 | US20070196526 Agent for substitution of blood plasma and a method of its production |
| 08/23/2007 | US20070196513 Synergistic mixture of plant extract from Cissus quadrangularis and soy albumin; may include chromium, selenium,green tea extract, vitamin B6, vitamin B12 and/or folic acid; obesity, insulin resistance or diabetes; eating disorders; anticholesterol and anorexigenic agents; reduction of triglyerides |
| 08/23/2007 | US20070196512 Combinations of vanadium with antidiabetics for glucose metabolism disorders |
| 08/23/2007 | US20070196501 Formulations for a tight junction effector |
| 08/23/2007 | US20070196499 Residual Solvent extraction method and microparticles produced thereby |
| 08/23/2007 | US20070196497 Pharmaceutical formulations for the prolonged release of active principle(s) and their applications |
| 08/23/2007 | US20070196459 Compositions and methods for treating dermatitis or psoriasis |
| 08/23/2007 | US20070196438 Compositions for the treatment of osteoarthritis and to nourish the synovial fluid |
| 08/23/2007 | US20070196433 Methods and devices for the sustained release of multiple drugs |
| 08/23/2007 | US20070196429 Proteins of natural origin and materials made therefrom |
| 08/23/2007 | US20070196416 Pharmaceutical compositions with enhanced stability |
| 08/23/2007 | US20070196396 Controlled release pharmaceutical compositions with improved bioavailability |
| 08/23/2007 | US20070196393 Recombinant Neospora antigens and their uses |
| 08/23/2007 | US20070196385 Method of treating hepatitis C infection |